Biomarkers for Prostate Cancer: From Diagnosis to Treatment

por Chen, Jia-Yan, Wang, Pei-Yan, Liu, Ming-Zhu, Lyu, Feng, Ma, Ming-Wei, Ren, Xue-Ying, Gao, Xian-Shu
Publicado 2023

Outcomes of High-Dose Stereotactic Ablative Radiotherapy to All/Multiple Sites for Oligometastatic Renal Cell Cancer Patients

por Ma, Ming-Wei, Li, Hong-Zhen, Gao, Xian-Shu, Liu, Ming-Zhu, Yin, Huan, Yang, Kai-Wei, Chen, Jia-Yan, Ren, Xue-Ying, Wang, Dian
Publicado 2022

Uncovering the Secrets of Prostate Cancer’s Radiotherapy Resistance: Advances in Mechanism Research

por Lyu, Feng, Shang, Shi-Yu, Gao, Xian-Shu, Ma, Ming-Wei, Xie, Mu, Ren, Xue-Ying, Liu, Ming-Zhu, Chen, Jia-Yan, Li, Shan-Shi, Huang, Lei
Publicado 2023

Population-Based Comparison of Different Risk Stratification Systems Among Prostate Cancer Patients

por Xie, Mu, Gao, Xian-Shu, Ma, Ming-Wei, Gu, Xiao-Bin, Li, Hong-Zhen, Lyu, Feng, Bai, Yun, Chen, Jia-Yan, Ren, Xue-Ying, Liu, Ming-Zhu
Publicado 2021

Dosimetric feasibility of stereotactic ablative radiotherapy in pulmonary vein isolation for atrial fibrillation using intensity‐modulated proton therapy

por Ren, Xue‐Ying, He, Peng‐Kang, Gao, Xian‐Shu, Zhao, Zhi‐Lei, Zhao, Bo, Bai, Yun, Liu, Si‐Wei, Li, Kang, Qin, Shang‐Bin, Ma, Ming‐Wei, Zhou, Jing, Rong, Yi
Publicado 2021